The interaction between B- and T-lymphocyte attenuator (BTLA), an inhibitory receptor whose extracellular domain belongs to the immunoglobulin superfamily, and herpesvirus-entry mediator (HVEM), a co-stimulatory tumour-necrosis factor receptor, is unique in that it is the only receptor-ligand interaction that directly bridges these two families of receptors. This interaction has raised many questions about how receptors from two different families could interact and what downstream signalling events might occur as a result of receptor ligation. As we discuss, recent studies show that engagement of HVEM with its endogenous ligand (LIGHT) from the tumour-necrosis factor family induces a powerful immune response, whereas HVEM interactions with BTLA negatively regulate T-cell responses.

Original languageEnglish
Pages (from-to)671-681
Number of pages11
JournalNature Reviews Immunology
Issue number9
StatePublished - Sep 2006


Dive into the research topics of 'Balancing co-stimulation and inhibition with BTLA and HVEM'. Together they form a unique fingerprint.

Cite this